Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN) Reports Licensee HLS Therapeutics Inc. Files NDA for Vascepa with Health Canada

April 29, 2019 6:09 AM
Amarin Corporation plc (NASDAQ: AMRN) today announced that its licensee in Canada, HLS Therapeutics Inc. (HLS), has filed a New ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Corporate News FDA Management Comments

Next Articles